Letrobol 2.5 (Letrozole USP 2.5mg) is an oral aromatase inhibitor. It works by significantly decreasing estrogen production in the body. Primarily prescribed as a breast cancer treatment, it is also utilized off-label to stimulate ovulation.
Lirafit Injection (Liraglutide 6 mg/ml) GLP-1 receptor agonist. It is prescribed alongside diet and exercise to manage type 2 diabetes, prevent cardiovascular events, and aid in weight management.
| Drug Class | GLP-1 (glucagon-like peptide-1) receptor agonist |
| Target Conditions | Obesity/Weight Management, Cardiovascular Risk Reduction |
| Dosage Form | Solution for Subcutaneous Injection in a Pre-filled Pen |
| Active Ingredient | Liraglutide (recombinant DNA) |
| Therapeutic Use | Anti-diabetic, metabolic |